Inappropriate -blocker prescribing after acute myocardial infarction (MI) is associated with greater mortality than appropriate prescribing

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1511, 2005-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased statin prescribing could reduce MI mortality

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 506, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Inappropriate prescribing common in elderly

By  

Reactions Weekly, Vol. 1, Iss. 1362, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Antibacterial prescribing inappropriate in Italy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Inappropriate prescribing of metformin discussed

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 377, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Tilarginine does not reduce the risk of mortality for patients with acute myocardial infarction (MI) and cardiogenic shock

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite